Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2020-09-03 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
DISCLOSEABLE TRANSACTION - THE SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS
Capital/Financing Update Classification · 95% confidence The document is an announcement from Uni-Bio Science Group Limited regarding a discloseable transaction involving the subscription of wealth management products. It details the subscription agreement, terms, reasons for the transaction, and regulatory implications under the Listing Rules. The content focuses on a specific capital investment transaction and its compliance with listing requirements. There are no financial statements, earnings data, or management discussion of financial results. The document is not a full financial report but an announcement of a capital/financing activity. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (8983 characters) supports it being a detailed announcement rather than a brief notice or a full report.
2020-09-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2020
Major Shareholding Notification Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 August 2020, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related instruments. The content is focused on share capital changes and securities movements rather than financial performance, management commentary, or regulatory certifications. It is a regulatory disclosure about share capital movements typically required by stock exchanges for listed companies. The document is not an annual or interim financial report, earnings release, or management discussion. It is a regulatory filing specifically reporting share capital movements and related securities information for a monthly period. Therefore, the most appropriate classification is 'Major Shareholding Notification' (MRQ), which covers notifications of changes in significant share ownership or share capital movements. Confidence is high given the detailed share capital movement data and the regulatory submission context.
2020-09-01 English
GRANT OF SHARE OPTIONS
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the grant of share options to directors of the company. It references compliance with the Listing Rules of the Hong Kong Stock Exchange and details the number of options granted, exercise price, vesting period, and names of directors receiving the options. The document is short (3182 characters) and is an announcement of a share option grant, which is a capital-related event but not a full financial report or earnings release. It does not contain financial statements or detailed financial analysis. This fits the category of a Share Issue/Capital Change announcement, as it relates to the issuance of share options (a form of capital change). Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2020-08-31 English
PROPOSED CHANGE OF AUDITOR
Audit Report / Information Classification · 95% confidence The document is an announcement regarding a proposed change of auditor for Uni-Bio Science Group Limited. It states that Deloitte has resigned and the Board proposes to appoint BDO Limited as the new auditor, subject to shareholder approval at an extraordinary general meeting. The document does not contain any audit report itself, nor detailed financial statements or audit results. It is a regulatory announcement about a change in auditor, which is related to board/management information but specifically about auditor change. Given the content and the nature of the announcement, it fits best under 'Audit Report / Information (AR)' category, which includes standalone audit reports and related announcements excluding full annual reports. The document is short (2967 characters) and is an announcement, not the audit report itself, but since it concerns auditor change, AR is the most appropriate classification rather than a general regulatory filing or board/management information. Confidence is high due to clear keywords like 'proposed change of auditor', 'resigned as auditor', and 'appointment of BDO as auditor'. FY 2020
2020-08-28 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2020
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2020' and contains detailed unaudited condensed consolidated interim financial results, including revenue, profit/loss, segment data, and management discussion and analysis for the six-month period ending June 30, 2020. It includes financial tables, business review, market review, and pipeline progress, all typical of an interim or quarterly report. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement or a certification. The presence of unaudited financial figures and detailed management discussion confirms it is an Interim / Quarterly Report (IR). H1 2020
2020-08-28 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is an announcement from Uni-Bio Science Group Limited regarding the date of a board meeting scheduled to approve and publish the interim financial results for the six months ended 30 June 2020. The document does not contain the actual interim financial results or substantive financial data but only announces the upcoming board meeting and the intention to approve and publish the interim results. The document length is short (1655 characters), and it serves as a notice rather than the report itself. According to the 'MENU VS MEAL' rule, this type of announcement is classified as a Report Publication Announcement (RPA).
2020-08-12 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.